Summary

Viral Respiratory Tract Infection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Viral Respiratory Tract Infection pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Viral Respiratory Tract Infection, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced from Global Marke...

Summary

Respiratory Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Respiratory Tract Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Respiratory Tract Infections, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced from Global Markets Direct’s p...

Summary

Acute Respiratory Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Acute Respiratory Failure pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Acute Respiratory Failure, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced from Global Markets Direct’s proprietar...

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Severe Acute Respiratory Syndrome (SARS) - Drugs In Development, 2022, provides an overview of the Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) pipeline landscape.

Severe acute respiratory syndrome (SARS) is a serious, potentially life-threatening viral infection caused by virus from the Coronaviridae family. Symptoms include cough, chills and shaking, headache, muscle aches, diarrhea, dizziness, nausea and vomiting. Risk factors include gene variation in the immune system and close contact with someone who has SARS.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Severe Acute Respiratory Syndrome (SARS) - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Severe Acute Respiratory Syndrome (SARS) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (R...

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Respiratory Distress Syndrome - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Acute Respiratory Distress Syndrome (Respiratory) pipeline landscape.

Acute respiratory distress syndrome (ARDS) occurs when fluid fills up the air sacs in lungs. This leads to low oxygen levels in the blood. Common causes of ARDS include sepsis, inhalation of harmful substances, severe pneumonia and head or chest injury. Signs and symptoms of ARDS include severe shortness of breath, labored and unusually rapid breathing, low blood pressure and confusion and extreme tiredness.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Acute Respiratory Distress Syndrome - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on the therapeutics under development for Acute Respirat...

Summary

Respiratory syncytial virus (RSV) is a common respiratory infection that most children will be infected with by the time they are two years old. In healthy individuals, RSV usually self-resolves within a week or two without need for significant therapeutic intervention. In preterm and very young infants, the elderly, or those with otherwise compromised immune systems, however, RSV can cause severe illness or death.

GlobalData epidemiologists provide a well-rounded, evidence-based analysis and forecast for the prophylactic populations for RSV in this report. This analysis covered all at-risk groups that are recommended for RSV prophylactic treatment. Several of the segmentations are further segmented by age, thereby providing a granular visualization of the RSV prophylactic and hospitalized market in the 8MM.

This report provides an overview of the risk factors, and global and historical trends for the RSV prophylactic population in the 8MM. It also includes a 10-year epidemiology forecast for the pediatric and adult populations that are most at ...

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2019, provides an overview of the Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) pipeline landscape.

Severe acute respiratory syndrome (SARS) is a serious, potentially life-threatening viral infection caused by virus from the Coronaviridae family. Symptoms include cough, chills and shaking, headache, muscle aches, diarrhea, dizziness, nausea and vomiting. Risk factors include gene variation in the immune system and close contact with someone who has SARS.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Severe Acute Respiratory Syndrome (SARS) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) ...

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Respiratory Distress Syndrome - Pipeline Review, H1 2019, provides an overview of the Acute Respiratory Distress Syndrome (Respiratory) pipeline landscape.

Acute respiratory distress syndrome (ARDS) occurs when fluid fills up the air sacs in lungs. This leads to low oxygen levels in the blood. Common causes of ARDS include sepsis, inhalation of harmful substances, severe pneumonia and head or chest injury. Signs and symptoms of ARDS include severe shortness of breath, labored and unusually rapid breathing, low blood pressure and confusion and extreme tiredness.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Acute Respiratory Distress Syndrome - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Acute Respiratory Distress Syndrome (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of ad...

Summary

GlobalData's clinical trial report, “Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Acute Respiratory Distress Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Respiratory Distress Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps t...

Summary

GlobalData's clinical trial report, “Acute Respiratory Failure Global Clinical Trials Review, H2, 2018" provides an overview of Acute Respiratory Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Respiratory Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter ...

Summary

GlobalData's clinical trial report, “Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H2, 2018" provides an overview of Acute Upper Respiratory Tract Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Upper Respiratory Tract Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilit...

Summary

GlobalData's clinical trial report, “Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Adult Respiratory Distress Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Adult Respiratory Distress Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps t...

Summary

GlobalData's clinical trial report, “Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2018" provides an overview of Viral Respiratory Tract Infection clinical trials scenario. This report provides top line data relating to the clinical trials on Viral Respiratory Tract Infection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to crea...

Summary

GlobalData’s new report, Germany Respiratory Procedures Outlook to 2025, provides key procedures data on the Germany Respiratory Procedures. The report provides procedure volumes within market segments - Aerosol Mask Procedures, Cardio-Pulmonary Resuscitation (CPR) Barrier Procedures, Nasal Cannula Procedures, Non-invasive Ventilation Mask & Circuit Procedures, Oxygen Mask Procedures, Positive End Expiratory Pressure (PEEP) Valve Procedures and Resuscitator Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treate...

Summary

GlobalData’s new report, Italy Respiratory Procedures Outlook to 2025, provides key procedures data on the Italy Respiratory Procedures. The report provides procedure volumes within market segments - Aerosol Mask Procedures, Cardio-Pulmonary Resuscitation (CPR) Barrier Procedures, Nasal Cannula Procedures, Non-invasive Ventilation Mask & Circuit Procedures, Oxygen Mask Procedures, Positive End Expiratory Pressure (PEEP) Valve Procedures and Resuscitator Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated po...

Summary

GlobalData’s new report, Spain Respiratory Procedures Outlook to 2025, provides key procedures data on the Spain Respiratory Procedures. The report provides procedure volumes within market segments - Aerosol Mask Procedures, Cardio-Pulmonary Resuscitation (CPR) Barrier Procedures, Nasal Cannula Procedures, Non-invasive Ventilation Mask & Circuit Procedures, Oxygen Mask Procedures, Positive End Expiratory Pressure (PEEP) Valve Procedures and Resuscitator Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated po...

Summary

GlobalData’s new report, Russia Respiratory Procedures Outlook to 2025, provides key procedures data on the Russia Respiratory Procedures. The report provides procedure volumes within market segments - Aerosol Mask Procedures, Cardio-Pulmonary Resuscitation (CPR) Barrier Procedures, Nasal Cannula Procedures, Non-invasive Ventilation Mask & Circuit Procedures, Oxygen Mask Procedures, Positive End Expiratory Pressure (PEEP) Valve Procedures and Resuscitator Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated ...

Summary

GlobalData’s new report, South Korea Respiratory Procedures Outlook to 2025, provides key procedures data on the South Korea Respiratory Procedures. The report provides procedure volumes within market segments - Aerosol Mask Procedures, Cardio-Pulmonary Resuscitation (CPR) Barrier Procedures, Nasal Cannula Procedures, Non-invasive Ventilation Mask & Circuit Procedures, Oxygen Mask Procedures, Positive End Expiratory Pressure (PEEP) Valve Procedures and Resuscitator Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed an...

Summary

GlobalData’s new report, China Respiratory Procedures Outlook to 2025, provides key procedures data on the China Respiratory Procedures. The report provides procedure volumes within market segments - Aerosol Mask Procedures, Cardio-Pulmonary Resuscitation (CPR) Barrier Procedures, Nasal Cannula Procedures, Non-invasive Ventilation Mask & Circuit Procedures, Oxygen Mask Procedures, Positive End Expiratory Pressure (PEEP) Valve Procedures and Resuscitator Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated po...

Summary

GlobalData’s new report, India Respiratory Procedures Outlook to 2025, provides key procedures data on the India Respiratory Procedures. The report provides procedure volumes within market segments - Aerosol Mask Procedures, Cardio-Pulmonary Resuscitation (CPR) Barrier Procedures, Nasal Cannula Procedures, Non-invasive Ventilation Mask & Circuit Procedures, Oxygen Mask Procedures, Positive End Expiratory Pressure (PEEP) Valve Procedures and Resuscitator Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated po...

Summary

GlobalData’s new report, Japan Respiratory Procedures Outlook to 2025, provides key procedures data on the Japan Respiratory Procedures. The report provides procedure volumes within market segments - Aerosol Mask Procedures, Cardio-Pulmonary Resuscitation (CPR) Barrier Procedures, Nasal Cannula Procedures, Non-invasive Ventilation Mask & Circuit Procedures, Oxygen Mask Procedures, Positive End Expiratory Pressure (PEEP) Valve Procedures and Resuscitator Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated po...